Showing results (81-90 of 424) with videos related to
Sort By:
Pageof 43
Therapeutic Advances in Gastroenterology|September 17, 2011
Glitazones for human nonalcoholic steatohepatitisRaluca Pais, Ioana Moraru, Vlad RatziuJournal of Hepatology|April 29, 2015
Current efforts and trends in the treatment of NASHVlad Ratziu, Zachary Goodman, Arun SanyalClinics and Research in Hepatology and Gastroenterology|April 16, 2018
Predictive value of liver damage for severe early complications and survival after heart transplantation: A retrospective analysisPascal Lebray, Shaida Varnous, Alina Pascale, et al.Journal of Hepatology|September 6, 2011
Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standardThierry Poynard, Victor de Ledinghen, Jean Pierre Zarski, et al.Comparative Hepatology|December 27, 2005
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosisThierry Poynard, Vlad Ratziu, Sylvie Naveau, et al.Clinics and Research in Hepatology and Gastroenterology|March 1, 2011
HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis CJean-Marc Costa, Dmytro Telehin, Mona Munteanu, et al.Clinics and Research in Hepatology and Gastroenterology|June 14, 2014
Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?"Hugo Perazzo, Raluca Pais, Mona Munteanu, et al.World Journal of Gastroenterology|August 31, 2011
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidenceShira Zelber-Sagi, Vlad Ratziu, Ran OrenClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 3, 2014
Significant variations in elastometry measurements made within short-term in patients with chronic liver diseasesFabio Nascimbeni, Pascal Lebray, Larysa Fedchuk, et al.Journal of Hepatology|July 13, 2014
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)Thierry Poynard, Julien Vergniol, Yen Ngo, et al.Pageof 43